Emibetuzumab
Emibetuzumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Eli Lilly and Company.
Mechanism of Action[edit | edit source]
Emibetuzumab is a monoclonal antibody that targets the MET receptor, also known as the hepatocyte growth factor receptor (HGFR). The MET receptor is often overexpressed in various types of cancer, including lung cancer, gastric cancer, and breast cancer. By binding to the MET receptor, emibetuzumab can inhibit the growth and proliferation of cancer cells.
Clinical Trials[edit | edit source]
Emibetuzumab has been evaluated in several clinical trials for its efficacy in treating various types of cancer. In a Phase II trial for non-small cell lung cancer, emibetuzumab showed promising results, with a significant number of patients experiencing a reduction in tumor size. However, further studies are needed to confirm these findings and to determine the optimal dosing regimen for this drug.
Side Effects[edit | edit source]
Like all drugs, emibetuzumab can cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, and diarrhea. Less common but more serious side effects can include liver damage, lung problems, and infusion reactions. Patients should discuss the potential risks and benefits of emibetuzumab with their healthcare provider before starting treatment.
See Also[edit | edit source]
References[edit | edit source]
Emibetuzumab Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD